What are the stages of Neonatal Encephalopathy (NE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neonatal encephalopathy is a condition that progresses through three distinct stages, with the most recent and highest quality evidence suggesting that therapeutic hypothermia is a crucial treatment for moderate to severe cases, as recommended in the 2024 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations 1. The stages of neonatal encephalopathy are characterized by:

  • Stage 1 (mild): hyperalertness, irritability, jitteriness, and a low threshold for the Moro reflex, typically occurring in the first 24 hours after birth
  • Stage 2 (moderate): lethargy, hypotonia, decreased spontaneous movements, and seizures, typically developing between 24-72 hours
  • Stage 3 (severe): stupor, flaccidity, absent reflexes, and suppressed brain activity, manifesting after 72 hours These stages reflect the evolving brain injury following hypoxic-ischemic events, with the progression correlating with increasing severity of neuronal damage, as noted in the 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care 1. The use of therapeutic hypothermia in term newborn infants with evolving moderate-to-severe hypoxic-ischemic encephalopathy is recommended, as it has been shown to reduce mortality and neurodevelopmental disability, as suggested by the 2024 international consensus 1. Early recognition of these stages is crucial for timely intervention, as the window for effective neuroprotection is narrow, and continuous EEG monitoring helps track brain function and detect subclinical seizures, which require prompt treatment to prevent further neuronal injury.

From the Research

Stages of Neonatal Encephalopathy

The stages of neonatal encephalopathy are not explicitly outlined in the provided studies. However, the studies discuss the severity of neonatal encephalopathy, which can range from mild to moderate to severe.

  • Mild neonatal encephalopathy may present with symptoms such as irritability and feeding difficulties 2.
  • Moderate to severe neonatal encephalopathy can present with symptoms such as depressed consciousness, difficulty initiating and maintaining respiration, and abnormal tone, reflexes, and neonatal seizures 3.

Causes and Treatment of Neonatal Encephalopathy

The causes of neonatal encephalopathy can be varied, including hypoxic-ischemic encephalopathy, infections, inflammation, toxins, metabolic disease, stroke, placental disease, and genetic disorders 2, 3.

  • Therapeutic hypothermia is a standard treatment for neonatal encephalopathy, particularly for moderate to severe cases 4, 5, 6.
  • The effectiveness of therapeutic hypothermia for mild neonatal encephalopathy is still being studied, with current evidence being insufficient to recommend routine use 6.

Epidemiology of Neonatal Encephalopathy

Neonatal encephalopathy is estimated to affect 2 to 6 per 1,000 term births, with hypoxic-ischemic encephalopathy accounting for approximately 1.5 per 1,000 term births 2.

  • The incidence of neonatal encephalopathy can vary depending on the country and income level, with higher rates in low- and middle-income countries 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management and investigation of neonatal encephalopathy: 2017 update.

Archives of disease in childhood. Fetal and neonatal edition, 2017

Research

Therapeutic hypothermia for neonatal encephalopathy.

Current opinion in pediatrics, 2015

Research

Therapeutic hypothermia for mild neonatal encephalopathy: a systematic review and meta-analysis.

Archives of disease in childhood. Fetal and neonatal edition, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.